Clinical Trial

Interim Results of Ongoing Clinical Trials May Be Misleading

Interim Results of Ongoing Clinical Trials May Be Misleading

By

Published interim results of ongoing clinical trials often report analyses without justification and may mislead clinicians about whether a particular drug or therapy is beneficial.

Reporting Negative Data in Clinical Trial Results

Reporting Negative Data in Clinical Trial Results

By

Increasingly, the scientific community is coming to realize the invaluable role that negative outcomes play in the understanding of medicine as a whole.

Phase 3 Trial for Sublingual Sufentanil for the Treatment of Moderate-to-Severe Acute Pain

Phase 3 Trial for Sublingual Sufentanil for the Treatment of Moderate-to-Severe Acute Pain

By

ARX-04 would provide a non-invasive option for moderate-to-severe acute pain in medical settings.

Sign Up for Free e-Newsletters